ORCID as entered in ROS
https://orcid.org/0000-0002-9460-2621
Select Publications
Conference Papers
, 2013, 'Impact of Gender on Radiation Dose from Percutaneous Coronary Intervention of Similar Complexity Quantified by 'Target-lesion' SYNTAX Score', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, CA, San Francisco, pp. B105 - B105, presented at
, 2013, 'Acute coronary syndrome care across Australia and New Zealand', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, NETHERLANDS, Amsterdam, pp. 732 - 733, presented at
, 2013, 'Has the frequency of peri-procedural myocardial infarction reduced using third universal definition?', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, NETHERLANDS, Amsterdam, pp. 227 - 227, presented at
, 2012, 'Clinical outcomes after bare-metal stents deployment in large coronary arteries in patients with ST-elevation myocardial infarction', in Journal of the American College of Cardiology, Elsevier Science Inc, New York, NY, USA, pp. 59 (13):E411-E411; S MAR 27 2012, presented at
, 2012, 'Left atrial volume and dynamics in chronic kidney disease', in European Heart Journal, W B Saunders Company Ltd, London, England, pp. 33 924-925; 1 AUG 2012, presented at
, 2008, 'Selective use of drug eluting stents in management of ST elevation acute myocardial infarction while maintaining a low further target revascularisation rate', in Heart Lung and Circulation, Blackwell Science Asia Pty Ltd, Australia, pp. 17;S101
, 2007, 'Efficient adjudication of endpoints in an international trial: Strategic lessons from the clinical events committee (CEC) of the assessment of pexelizumab in acute myocardial infarction (APEX AMI) trial', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, FL, Orlando, pp. 317 - 317, presented at
, 2006, 'Differences between site-reported and core laboratory creatine kinase-MB values in an international clinical trial: Results from the SYNERGY trial', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, pp. 421 - 421, presented at
, 2006, 'Do patients with heart failure appropriately undergo invasive procedures post myocardial infarction? Results of a multi-centre study', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, SPAIN, Barcelona, pp. 355 - 355, presented at
, 2006, 'Platelet responsiveness to aspirin and cloidogrel and troponin increment after intervention in acute coronary lesions: results of the Practical trial', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, SPAIN, Barcelona, pp. 653 - 653, presented at
, 2006, 'Prospective evaluation of criteria for selective drug eluting stent deployment during angioplasty', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, SPAIN, Barcelona, pp. 769 - 769, presented at
, 2005, 'A simple prognostic score for the re-infarction risk following fibrinolytic therapy for myocardial infarction - data from HERO-2', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, SWEDEN, Stockholm, pp. 561 - 561, presented at
, 2005, 'Anti-platelet therapy and progression of coronary artery disease after myocardial infarction: a placebo-controlled trial with angiographic and clinical follow-up', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, SWEDEN, Stockholm, pp. 136 - 136, presented at
, 2003, 'Reversal of systemic hypoperfusion following intra-aortic balloon pumping is associated with improved 30-day survival independent of early revascularization in cardiogenic shock complicating an acute myocardial infarction', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, FLORIDA, ORLANDO, pp. 672 - 673, presented at
, 2003, 'Recurrent ST-elevation in a different territory to the index infarct after fibrinolytic therapy: a manifestation of multiple unstable plaques', in EUROPEAN HEART JOURNAL, W B SAUNDERS CO LTD, AUSTRIA, VIENNA, pp. 270 - 270, presented at
, 2003, 'Treatment of reinfarction is associated with 30-day survival - regional geographic variations in treatment and outcomes following reinfarction in the HERO-2 trial', in EUROPEAN HEART JOURNAL, W B SAUNDERS CO LTD, AUSTRIA, VIENNA, pp. 300 - 300, presented at
, 2003, 'Blinded adjudication of reinfarction following fibrinolysis: Data from the HERO-2 trial', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, ILLINOIS, CHICAGO, pp. 375A - 375A, presented at
, 2003, 'C-reactive protein is increased in aortic stenosis but not aortic regurgitation', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, ILLINOIS, CHICAGO, pp. 497A - 497A, presented at
, 2003, 'Effect of simvastatin on the inflammatory response to coronary angioplasty', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, ILLINOIS, CHICAGO, pp. 22A - 22A, presented at
, 2003, 'Natriuretic peptide plasma levels remain elevated six months after aortic valve replacement for severe aortic stenosis', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, ILLINOIS, CHICAGO, pp. 508A - 508A, presented at
, 2003, 'Neither periprocedural pregnancy-associated plasma protein A nor C-reactive protein levels predict restenosis', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, ILLINOIS, CHICAGO, pp. 22A - 23A, presented at
, 2003, 'Regional variations in treatments and outcomes of reinfarction in the HERO-2 trial', in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, ILLINOIS, CHICAGO, pp. 347A - 347A, presented at
, 2003, 'A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction', in American Heart Journal, pp. 508 - 514, http://dx.doi.org/10.1067/mhj.2003.184
, 2003, 'Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction', in American Heart Journal, pp. 118 - 124, http://dx.doi.org/10.1067/mhj.2003.29
, 2002, 'Regular exercise training does not lower serum C-reactive protein levels in healthy elderly subjects', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, ILLINOIS, CHICAGO, pp. 615 - 616, presented at
, 2000, 'Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction', in Journal of the American College of Cardiology, pp. 717 - 722, http://dx.doi.org/10.1016/S0735-1097(00)00772-5
, 1999, 'Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial', in AMERICAN HEART JOURNAL, MOSBY-ELSEVIER, GA, ATLANTA, pp. 804 - 810, presented at
, 1999, 'Survival 12 years after randomization to streptokinase: The influence of thrombolysis in myocardial infarction flow at three to four weeks', in Journal of the American College of Cardiology, pp. 62 - 69, http://dx.doi.org/10.1016/S0735-1097(99)00166-7
Conference Posters
, 2023, 'DISPARITIES IN STEMI OUTCOMES AMONGST INDIGENOUS AND NON-INDIGENOUS AUSTRALIANS: A 5 YEAR OBSERVATIONAL COHORT STUDY', Vol. 81, pp. 962 - 962, http://dx.doi.org/10.1016/s0735-1097(23)01406-7
, 2023, 'SMOKING STATUS AND CLINICAL OUTCOMES IN PATIENTS WITH ST-SEGMENT ELEVATION MI', Vol. 81, pp. 2279 - 2279, http://dx.doi.org/10.1016/s0735-1097(23)02723-7
, 2022, 'LATE CLINICAL OUTCOMES OF PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION(STEMI) TREATED BY EITHER PHARMACO-INVASIVE OR PRIMARY PCI', Vol. 79, pp. 671 - 671, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000781026600672&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'PO165 Simple Indices of Infarct Size Post ST-Elevation Myocardial Infarction (STEMI) Provides Similar Risk Stratification to Cardiac MRI', Vol. 13, pp. 417 - 417, http://dx.doi.org/10.1016/j.gheart.2018.09.147
Conference Presentations
, 2022, 'Reperfusion strategy and late clinical outcomes of patients with ST-elevation myocardial infarction (STEMI) in the absence of standard modifiable risk factors (SMuRFs)', http://dx.doi.org/10.1093/eurheartj/ehac544.2034
, 2022, 'Contrasting the Benefits of Early Invasive Angiography in Acute and Chronic Myocardial Injury', http://dx.doi.org/10.1016/j.hlc.2022.06.327
, 2022, 'Intravascular Lithotripsy versus Rotational Atherectomy Cutting Balloon on Stent Expansion for Heavily Calcified Coronary Lesions', http://dx.doi.org/10.1016/j.hlc.2022.06.599
, 2022, 'Reperfusion Strategy and Late Clinical Outcomes of Patients With ST-Elevation Myocardial Infarction (STEMI) Without Standard Modifiable Risk Factors (SMuRFs)', http://dx.doi.org/10.1016/j.hlc.2022.06.619
, 2022, 'Ultrasound Guidance Facilitates Ideal Femoral Puncture for Coronary Angiography', http://dx.doi.org/10.1016/j.hlc.2022.06.640
, 2021, 'Abstract 6984: Cost Effectiveness of a 1-Hour High-Sensitivity Troponin-t Protocol in Suspected Acute Coronary Syndrome: A Trial-Based Analysis of the Rapid-tnt Randomised Trial', http://dx.doi.org/10.1161/circ.144.suppl_1.6984
, 2021, 'Brachial Artery Flow-Mediated Vasodilation is Related to the Coronary Index of Microcirculatory Resistance in Non-ST Elevation Acute Coronary Syndrome', http://dx.doi.org/10.1016/j.hlc.2021.06.262
, 2021, 'Initial Experience with Intravascular Lithotripsy with Shockwave Balloon for Calcified Coronary Lesions During Percutaneous Coronary Intervention (PCI)', http://dx.doi.org/10.1016/j.hlc.2021.06.485
, 2021, 'Management of Rural Acute Coronary Syndromes (MORACS) A Cluster, Randomised Controlled Trial', http://dx.doi.org/10.1016/j.hlc.2021.06.008
, 2021, 'Simple Indices of Infarct Size Post ST-Elevation Myocardial Infarction (STEMI) Provides Similar Risk Stratification to Cardiac MRI', http://dx.doi.org/10.1016/j.hlc.2021.06.330
, 2021, 'Ticagrelor is Superior to Clopidogrel in Preserving Vasodilatory Capacity of the Coronary Microcirculation After Non-ST Elevation Acute Coronary Syndrome', http://dx.doi.org/10.1016/j.hlc.2021.06.510
, 2012, 'Long Term Impact of Restrictive Filling Pattern post Acute Myocardial Infarction', http://dx.doi.org/10.1016/j.hlc.2012.05.111
, 2002, 'Increasing left ventricular sphericity is associated with decreased survival even in patients with TIMI-3 flow or inferior infarction', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000174106701491&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2002, 'International differences in patients, care, and outcomes associated with acute myocardial infarction: The HERO-2 trial', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000174106701258&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2001, 'A clinical score at 60 minutes predicts failure to achieve TIMI 3 flow 90 minutes following thrombolytic therapy.', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000171895003664&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2001, 'Characterization of types of myocardial infarctions in two large acute coronary syndrome trials', Vol. 104, pp. 697 - 698, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000171895003264&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Conference Abstracts
, 2023, 'Differences in Long-Term Clinical Outcomes Amongst Smokers and Non-Smokers Following ST-Elevation Myocardial Infarction (STEMI)', in Heart, Lung and Circulation, Elsevier BV, Vol. 32, pp. S279 - S280, http://dx.doi.org/10.1016/j.hlc.2023.06.368
, 2023, 'Late Outcomes Following ST-Elevation Myocardial Infarction Amongst Indigenous and Non-Indigenous Australians', in Heart, Lung and Circulation, Elsevier BV, Vol. 32, pp. S378 - S378, http://dx.doi.org/10.1016/j.hlc.2023.06.492
Filter by type
https://orcid.org/0000-0002-9460-2621